期刊文献+

血浆置换治疗肝功能衰竭的临床疗效与生存质量分析 被引量:2

Clinical effi cacy and quality of life analysis of plasma exchange in the treatment of liver failure
下载PDF
导出
摘要 目的探讨血浆置换治疗肝功能衰竭患者的临床疗效、不良反应及生存质量。方法收集103例肝功能衰竭患者进行血浆置换治疗。观察患者治疗前后肝功能指标及生存质量的变化以及治疗后不良反应的发生情况。应用SPSS统计软件进行数据分析。结果 103例患者血浆置换治疗后,TBil、ALT、AST、PTA、CHE与治疗前比较均有明显提升(P<0.05);治疗后不良反应的发生以过敏反应为主;患者治疗后生存质量各维度与治疗前相比,均有显著改善,差异有统计学意义(P<0.05)。结论血浆置换治疗肝功能衰竭具有较好的临床效果,同时能有效提高患者的生存质量,但应警惕不良反应的发生。 Objective To investigate the effi cacy, adverse reactions and quality of life of plasma exchange in the treatment of liver failure. Methods Total of 103 patients with liver failure, and all subjects were treated with plasma exchange for determination of the changes in the liver function indices and adverse reactions, as well as quality of life. SPSS was used to analyze the data. Results Following plasma exchange, there had a signifiant difference in TBil, ALT, AST, PTA and CHE levels(P〈 0.05). The major adverse reactions comprised of plasma allergic reactions. The quality of life in all dimensions had a signifi ant improvement than that of pre-treatment(P〈 0.05). Conclusions Plasma exchange achieves siginifi cant effi cacy and quality of life for the treatment of liver failure, but should warrant prevention of the complications.
出处 《中国肝脏病杂志(电子版)》 CAS 2014年第4期51-53,共3页 Chinese Journal of Liver Diseases:Electronic Version
关键词 肝功能衰竭 血浆置换 生活质量 Liver failure Plasma exchange Quality of life
  • 相关文献

参考文献6

二级参考文献43

  • 1段钟平.重型肝炎肝衰竭临床治疗进展[J].中国实用内科杂志,2005,25(9):784-786. 被引量:29
  • 2武文芳,张晶,马斌荣,段钟平.重型肝病患者人工肝治疗的生存分析[J].首都医科大学学报,2007,28(2):249-251. 被引量:7
  • 3陈明亮 刘三都.肝纤维化的基础研究及临床[M].北京:人民出版社,1996.231-245.
  • 4Mitzner SR,Stange J,Klammt S,et al.Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure[J].J Am Soc Nephrol,2001 Feb.12 suppl 17:s75-82.
  • 5Sen S,Jalan R.The role of the Molecular Adsorbents Recirculating System(MARS)in the management of liver failure[J].Perfusion,2004,19 Suppl 1:S43-48.
  • 6Jalan R,Sen S,Steeiner C,et al.Extracorporeal liver support with molecular adsorbents recirulating system in patients with severe acute alcoholic hepatitis[J].J Hepatol,2003,38:24-31.
  • 7De Silvestro G.Marson P,Brandolese R,et al.A Single institution 抯 experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure[J].Int J Artif organs,2000 Jul,23:454-461.
  • 8Di Campli C,Zileri Dal Verme L,Andrisani MC,et al.Advances in extracorporeal detoxification by MARS dialysis in patients with liver failure[J].Carr Med Chem,2003,10:341-348.
  • 9Bernuau J,Rueff B,Benhamou JP.Fulminant and subfulminant liver failure:definitions and causes.Semin Liver Dis 1986;6:97-106.
  • 10Yoshiba M,Inoue K,Sekiyama K,Koh I.Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.Artif Organs 1996;20:1169-1172.

共引文献31

同被引文献28

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部